Alcon, a Swiss-American eye care company, has raised its profit guidance and lowered its estimate for the full-year tariff impact to $40 million to $90 million. The company expects its core operating profit margin to grow by 90-190 basis points in 2026.
Alcon’s net sales in the second quarter rose to $2.78 billion, from $2.58 billion a year ago, narrowly beating analysts’ consensus. The U.S. accounted for 45% of Alcon’s net sales in the first half of the year, and most of its major production facilities are located there.
Original reporting: Appleton, WI News Feed (HLL/CB) — read the source article.
